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Abstract 
This review concludes that a sedentary lifestyle, obesity and ageing impair the vasodilator 
response of the muscle microvasculature to insulin, exercise and VEGF-A and reduce 
microvascular density. Both impairments contribute to the development of insulin resistance, 
obesity and chronic age related diseases. A physically active lifestyle keeps both the 
vasodilator response and microvascular density high.  Intravital microscopy has shown that 
microvascular units (MVUs) are the smallest functional elements to adjust blood flow in 
response to physiological signals and metabolic demand of muscle fibres. The luminal 
diameter of a common terminal arteriole (TA) controls blood flow through upto 20 capillaries 
belonging to a single MVU. Increases in plasma insulin and exercise/muscle contraction lead 
to recruitment of additional MVUs. Insulin also increases arteriolar vasomotion. Both 
mechanisms increase the endothelial surface area and therefore transendothelial transport of 
glucose, fatty acids (FA) and insulin by specific transporters, present in high concentrations 
in the capillary endothelium. Future studies should quantify transporter concentration 
differences between healthy and at risk populations as they may limit nutrient supply and 
oxidation in muscle and impair glucose and lipid homeostasis. An important recent discovery 
is that VEGF-B produced by skeletal muscle controls the expression of FA transporter 
proteins in the capillary endothelium and thus links endothelial FA uptake to the oxidative 
capacity of skeletal muscle, potentially preventing lipotoxic FA accumulation, the dominant 
cause of insulin resistance in muscle fibers. 
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Introduction 
The aim of this symposium review is to provide an introduction and fill in the background 
knowledge for the subsequent reviews presented at Physiology 2014 in London in an Invited 
Symposium with the title: "Impact of physical activity, ageing, obesity and metabolic 
syndrome on muscle microvascular perfusion and endothelial metabolism". Increases in 
plasma insulin (following meal ingestion or insulin infusion) lead to modest increases in 
resting skeletal muscle blood flow and/or microvascular blood volume via an endothelial 
nitric oxide (NO) dependent mechanism. During aerobic endurance exercise the blood flow 
in the contracting skeletal muscles increases upto 80-fold compared to rest via a number of 
complementary mechanisms. In both cases more blood is present in or flowing through the 
muscle capillary bed, but the mechanisms by which these increases in muscle capillary blood 
flow occur are only partially understood. This review, therefore, will first explain the 
complex anatomy of the microvasculature in mammalian skeletal muscles, as a proper 
understanding of the anatomy is integral to understanding of the nature and mechanisms that 
control muscle capillary blood flow and the supply of oxygen, fuels and hormones to the 
skeletal muscle fibres. This will be followed by reflections on the metabolic rationale for the 
very large surface area of the endothelial cell layer (ECL) in the skeletal muscle 
microvasculature, especially the role that it plays in the transendothelial transport of oxygen, 
glucose, fatty acids (FA) and insulin from the lumen of the muscle capillaries into the 
interstitial fluid surrounding the skeletal muscle fibres. Finally, a summary will be given of 
the mechanisms by which meal-induced increases of plasma insulin and exercise induced 
increases in blood shear stress and in the interstitial concentration of vascular endothelial 
growth factor-A (VEGF-A) activate endothelial nitric oxide synthase (eNOS), dilate terminal 
arterioles (TAs) and thus increase capillary blood flow. The important role of these molecular 
mechanisms in maintaining optimal insulin sensitivity, glucose and lipid homeostasis, 
skeletal muscle perfusion during exercise and the angiogenic response to regular exercise will 
first be explained in healthy physically active individuals and intervened with a 
comprehensive summary of the most important impairments that occur in sedentary, obese 
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Why  are  insulin  induced  increases  in  skeletal  muscle  blood  perfusion  important?  
Research using contrast-enhanced ultrasound has shown that meal induced increases in the 
plasma insulin concentration lead to small (+50-80%) increases in the resting blood volume 
of the skeletal muscle microvascular bed in lean healthy individuals (Vincent et  al. 2006). 
Convincing evidence has been delivered that this increase in micovascular blood volume 
leads to increased capillary recruitment in skeletal muscle both in rats (Rattigan et  al. 1997) 
and humans (reviewed by Keske et  al. unpublished symposium review). These increases are 
important, as they are part of the redistribution of the fuels that are absorbed with each of the 
main meals and, therefore, play an important role in the delivery of glucose, insulin and fatty 
acids to skeletal muscle as the main storage site. Following oral ingestion of a 92 gram 
glucose load leading to physiological increases in plasma insulin in healthy lean young males, 
65-70% of the ingested glucose was taken up by peripheral tissues (Katz et   al. 1983). 
Following oral ingestion of a mixed meal (40 g fat and 40 g carbohydrate) a substantial part 
of the meal-derived fat was taken up by cannulated forearm and abdominal subcutaneous 
adipose tissue as chylomicron-triglyceride (TG) and VLDL-TG (Bickerton et   al. 2007). 
These studies collectively suggest that the peripheral tissues (primarily skeletal muscle and 
subcutaneous adipose tissue) make the largest contributions to the clearance of orally 
ingested glucose and lipid and, therefore, make an important contribution to postprandial 
glucose and lipid homeostasis. Postprandial increases in perfusion of the skeletal muscle 
microvascular bed, therefore, seem to be instrumental for glucose and lipid homeostasis and 
long-term metabolic health. However, studies with contrast enhanced ultrasound have shown 
that physiological, meal-induced and supraphysiological increases in plasma insulin achieved 
via a hyperinsulinemic euglycemic clamp fail to increase the blood volume that is present in 
the skeletal muscle microvascular bed in obese individuals (Clerk et  al. 2006; Keske et  al. 
2009) and also in sedentary elderly individuals, type 2 diabetes patients and animal models of 
type 2 diabetes and insulin resistance (for references see reviews of Barrett et  al. 2009 and 
Keske et   al. unpublished symposium review). This suggest that the postprandial 
redistribution of the blood flow to skeletal muscle and potentially subcutaneous adipose 
tissue is reduced or absent in obese, elderly and insulin resistant individuals. This impairment 
explains the large transient increases that are seen in plasma glucose and TG concentrations 
following ingestion of mixed meals in these conditions. It is the prevalence and height of the 
elevated postprandial glucose excursions, which represents a high risk for development of 
type 2 diabetes (Abdul-Ghani & deFronzo, 2009) and which imposes a direct and 
independent risk in type 2 diabetes patients for the development of cardiovascular 
complications (Ceriello 2005). Increased postprandial plasma TG concentrations also 
presented an independent risk for the development of cardiovascular events and insulin 
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Why  are  exercise-­induced  increases  in  skeletal  muscle  blood  perfusion  important?  
The microvasculature of human skeletal muscles has a complex 3D-structure and is subject to 
a large number of complementary blood flow regulation mechanisms (Mortensen & Saltin, 
2014). This ensures that blood supply matches the metabolic demands of the muscle fibres 
under resting conditions and during exercise. The energy expenditure of skeletal muscle in 
comparison to other tissues and organs is relatively low at rest (0.5 watt/kg muscle), but can 
increase during aerobic exercise (e.g. during running at Olympic level marathon pace) to 80 
watt/kg of contracting muscle. This is a 160-fold increase, which trained athletes are able to 
maintain for more than 2 h, because the density of both the mitochondrial network (ATP 
production capacity) and the microvascular network (oxygen and fuel supply) is much higher 
in endurance trained athletes than in sedentary individuals (Saltin et  al. 1977; Saltin 1988). 
All the oxygen and blood borne fuels (glucose, fatty acids and lipoprotein TGs) required to 
meet this high energy demand are delivered to the muscle via the blood (Van Loon et   al. 
2001). It is for this reason that leg blood flow and perfusion of the muscle microvascular bed 
have to increase 10-80 fold (depending on running velocity and training status) during two-
legged running. When the active muscle mass is small and the heart (cardiac output) is not a 
limitation, skeletal muscle blood flow in trained individuals can even increase 100-fold and 
reach perfusion rates of 300-400 ml/min per kg muscle (Andersen & Saltin, 1985; Richardson 
et  al. 1993). A thorough knowledge of the anatomy of the muscle microvasculature to include 
the role played by the ECL and TAs in channeling blood borne fuels into the muscle 
interstitium is essential for a basic understanding of the mechanism by which aerobic 
endurance exercise leads to these 10 to100-fold increases in skeletal muscle microvascular 
perfusion and metabolic rate.  
Functional anatomy of the microvasulature of skeletal muscle 
Most of the historic thinking about the supply and utilization of oxygen and glucose in human 
skeletal muscle is based on spatial relationships of capillaries and skeletal muscle fibres 
measured in skeletal muscle cross-sections (e.g. Krogh 1918) (Fig. 1A). This remains 
common practice today as the generation of longitudinal and 3-dimensional (3D) images of 
the microvasculature in human muscle fibres currently is an insurmountable methodological 
challenge. The length of human muscle fibres is between 4 cm (soleus muscle) and 40 cm 
(sartorius muscle) (Wickiewicz et   al. 1983; Ward et   al. 2009), while the diameter of 
capillaries is in the 6-10 µm range. The capillaries, furthermore, are densely packed between 
the plasma membranes of neighbouring muscle fibres, which have a diameter of 50-90 µm 
depending on fibre type, age and training status. The imaging problems that result from this 
spatial organisation seem to be the reason that today there is very little published information 
on the 3D anatomical structure of the human skeletal muscle microvasculature. We, 
therefore, depend on information from other mammalian species to build up a basic 
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Fig. 1B and 1C show images of a plaster cast of the highly branched network of the 
microvasculature of the mouse gluteus maximus muscle originally published by Segal (2005). 
A more recent educational description, linking anatomy to blood flow control in skeletal 
muscle, has been published by Segal & Bearden (2012) again in mouse gluteus maximus 
muscle. In brief upon leaving the heart, the convection of blood through large conduit arteries 
such as the brachial and femoral arteries rapidly conveys blood to skeletal muscle with 
minimal hemodynamic resistance. The large conduit arteries then split into muscular feed 
arteries, which are millimeters wide in humans and are still external to skeletal muscles. 
These feed arteries are positioned to control the total amount of blood entering the muscle 
and are assumed to present close to half of the total resistance to blood flow (Segal & 
Bearden, 2012). Upon entering skeletal muscle, feed arteries branch into the arteriolar 
networks, which are assumed to provide the major resistance to blood flow (Segal & 
Bearden, 2012). Primary or 1st order arterioles branch into 2nd and 3rd order arterioles (Figure 
2A). These intermediate branches distribute blood along the full length and full depth of the 
muscle and thereby control regional perfusion. Arising from the distributing 3rd order 
arterioles are the 4th order and terminal or 5th order arterioles (TAs). The TAs control the 
perfusion of capillaries with red blood cells.  
Capillaries  are  organised  into  microvascular  units  (MVUs)  
Capillaries in mouse gluteus maximus muscle (Segal 1985; Segal and Bearden, 2012) and in 
hamster tibialis anterior muscle (Lund et  al. 1987; Delashaw & Duling, 1988) are organised 
into microvascular units (MVUs). The latter represent the smallest volume of muscle to 
which blood flow and, therefore, oxygen, glucose and fatty acids (fuel) and insulin (hormone) 
delivery can be independently controlled. MVUs consist of all the capillaries arising from a 
common TA. TAs are oriented perpendicular to muscle fibres branching into a group of about 
20 capillaries that run along the length of and between muscle fibres for a distance of about 1 
mm.  Usually blood flow in half of the capillaries is in one direction, and in the other half in 
the opposite direction, along the length of the same muscle fibres. The two sections of the 
MVU with flow in opposite direction have been named a "unit pair" (Lund et  al. 1987). The 
capillaries empty on both sides into collecting venules (CV's, Fig. 2B). The volume of muscle 
tissue within an MVU with 2 unit pairs has been estimated at 0.2 mm3 (or 2 mg), with 
average dimensions being 2 mm long, 0.5 mm wide, and 0.2 mm thick. This volume contains 
segments of about 20 different muscle fibres, which must originate from different motor units 





This article is protected by copyright. All rights reserved.   7 
 
Control  of  blood  flow  in  microvascular  units  
In order to investigate the control of the blood flow in the capillaries of individual MVUs and 
potential differences between adjacent MVUs Lund et   al. (1987) and Delashaw & Duling 
(1988) performed an impressive series of experiments in which they removed the skin and 
fascia from the tibialis anterior muscle in anesthetised hamsters. This allowed these 
researchers to use intravital epifluorescence microscopy to visualise the flow of red blood 
cells from the TA through capillaries to the CV in the 160-180 µm layer (one MVU deep) 
immediately below the surface of the muscle. When this preparation in control experiments 
was superfused with a Krebs-Ringer buffer that did not contain oxygen basically all the 
capillaries in all MVUs were continuously perfused with blood. Exposure to a superfusate 
containing 10% O2 typically resulted in closure of approximately 50% of the capillaries, with 
the blood flow being simultaneously arrested in all capillaries of a given MVU by complete 
closure of the TA. An important observation in these studies was that in the MVUs, that 
remained to be perfused, the blood flow in all capillaries showed rhythmic oscillations, which 
were attributable to a spontaneous rhythmic change of the diameter of its TA. This 
phenomenon was called arteriolar 'vasomotion'. During vasomotion, flow in all of the 
capillaries of a given MVU tended to vary in synchrony with same phase and frequency (3-6 
cycles per minute), while phase and frequency tended to vary between adjacent MVUs.  
Delashaw & Duling (1988) in the same muscle preparation investigated the effects of 1) 
direct electrical stimulation leading to muscle contractions, 2) topical application of 
adenosine (vasodilator) and 3) topical application of phenylephrine (vasoconstrictor). The 
predominant response to these stimuli again consisted of a coordinated change in the blood 
flow in virtually all the capillaries of the investigated MVUs. Electrical stimulation of 
muscles in which blood flow was arrested in 95% of the MVUs led to the simultaneous 
recruitment of virtually all capillaries (of both unit pairs) in previously closed MVUs. Topical 
application of adenosine had a similar result, while topical application of phenylephrine 
resulted in the simultaneous arrest of the blood flow in all capillaries of previously perfused 
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The study of Lund et  al. (1987) also revealed that capillaries of neighbouring MVUs often 
run in parallel and overlap and cross with each other, implying that multiple MVUs supply 
oxygen, fuel and insulin to the same sections of the same muscle fibres. The flow in adjacent 
MVUs was both concurrent and countercurrent with 25-50% of the adjacent capillaries 
having a countercurrent flow. Suggestions have been made that the % countercurrent flow is 
around 50% for capillaries in deeper muscle layers originating from adjacent MVUs on both 
sides. Such a mixed concurrent-countercurrent flow pattern allows for the diffusion of 
oxygen between adjacent capillaries and on theoretical grounds has been suggested to give 
the most homogeneous type of tissue oxygenation (Grunewald & Sowa, 1977). In more 
recent studies (reviewed by Pittman (2013)) convincing evidence has also been presented that 
muscle arterioles also exchange oxygen via diffusion to adjacent capillaries (which they often 
cross) and that oxygen diffusion occurs between arteriole-venule pairs which often run next 
to each other over distances upto several mm (Fig 1B).  
Relevance  of  these  findings  for  resting  and  contracting  human  skeletal  muscles  
Although the above studies have generated a wealth of information on MVUs in skeletal 
muscle of anesthetised hamsters a major problem that remains is how to relate these findings 
to intact undisturbed human skeletal muscles in the in  vivo resting state and during exercise 
or contraction. As the same structural organisation and similar size of MVUs has also been 
observed in rabbit tenuissimus muscle (Lindbom 1983) and in monkey skeletal muscle 
(Weibel, 1984), it is assumed in this review that this will also be the case for other 
mammalian species to include man. A limitation of the superfused hamster muscle 
preparations indicated by Lund et  al. (1987) is that the PO2 of the superfusion buffer has a 
major impact on vasoconstiction and vasomotion of TAs and therefore on capillary blood 
flow in MVUs. As such it was not possible for Lund et  al. (1987) to decide what the 'normal' 
state in this muscle is. Is it the continuous perfusion of all MVUs and capillaries observed 
with a superfusion solution containing no oxygen (condition 1), or the mixture of closed 
MVUs and  MVUs showing cyclic vasomotion observed with a superfusion solution gassed 
with 10% oxygen (condition 2)? The vasodilatation observed during chronic electrical 
stimulation and in response to adenosine and the vasoconstriction seen in response to 
phenylephrine in condition 2 (Delashaw & Duling, 1988) is very similar to in  vivo effects of 
voluntary exercise and of arterial infusion of adenosine and phenylephrine on limb and local 
muscle blood flow seen in humans in   vivo. Cyclic vasomotion of the skeletal muscle 
microvasculature has also been studied in rats in  vivo with laser Doppler flowmetry (LDF) 
with insertion of the probe in the tibialis muscle parallel to the muscle fibre direction 
(Newman et  al. 2009). This study revealed that vasomotion occurred with a frequency in the 
range of 6 cycles per minute, which is in the same frequency range as observed by Lund et  al. 
(1987) in MVUs of the hamster tibialis anterior muscle using a superfusion solution gassed 
with 10% oxygen.  
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Assumptions   on   the   regulation   of   capillary   blood   flow   in   human   skeletal   muscle  
currently  not  supported  by  human  data  
In the remainder of this review, therefore, the assumptions will be made that there are similar 
size MVUs in human skeletal muscles fibres as in other mammalian species and that part of 
these MVUs will be closed in the normal resting state, while others undergo cyclic 
vasomotion with a large variation in the perfusion rate between adjacent MVUs. Cyclic 
vasomotion of TAs in combination with a mixed concurrent-countercurrent flow pattern in 
adjacent capillaries (originating from adjacent MVUs) is assumed to play an important role in 
ensuring that skeletal muscles are evenly perfused by periodically redistributing blood from 
one MVU to adjacent ones. Vasomotion will allow switches in time both in recruitment of 
different MVUs and in the overall blood perfusion rate of a given MVU by step-wise changes 
in the lumen of the common TA. Vasomotion as such may contribute to the local blood flow 
control mechanism that can lead to an even perfusion rate over the full length of the upto 40 
cm long multinucleated muscle fibres in human skeletal muscle and may also help to ensure 
that the approximately 20 fibre sections that are present in a single MVU are perfused in 
proportion to their metabolic demand. Please note that future research is required to confirm 
these assumptions. 
Anatomy and function of the endothelial cell layer in the microvasculature of human 
skeletal muscle 
Every blood vessel in the human vasculature is covered on the luminal side with a continuous 
monolayer of ECs (ECL). The total surface area of the ECL in an adult human has been 
estimated to cover > 700 m2 and to have a weight of about 700 g (Wolinsky, 1980). This 
makes the ECL into one of the largest diffuse tissues in the human body with a significant 
weight despite the 0.3 µm thickness. The ECL of all arteries and veins in our body together 
covers only about 6 m2 (Fig. 1D), while the ECL of the microvasculature (arterioles, 
capillaries and venules) contributes 99% of the total surface area. Of the latter 85% (about 
600 m2) is present in capillaries (Fig. 1D). As skeletal muscle in a 70 kg lean physically 
active adult has a mass between 35 kg and 40 kg and has a higher capillary density than other 
tissues (with exception of the heart), estimates are that at least 400 m2 of the ECL is present 
in the skeletal muscle microvasculature, again with the largest surface area in the dense 
network of capillaries (Wolinsky, 1980). The metabolic rationale behind this distribution 
seems to be that the ECL in muscle capillaries contains all the enzymes that facilitate the 
transendothelial transport of glucose, amino acids, fatty acids and insulin into the interstitial 
fluid that surrounds the muscle fibres and that transport capacity, therefore, can be increased 
by recruiting a larger endothelial surface area at times of increased metabolic demand (eg 
following meal ingestion and during exercise).  
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Transendothelial  transport  of  oxygen,  nutrients  and  insulin  
ECs in the skeletal muscle microvasculature form a continuous mono-layer and as such 
present the first potential barrier for the transport of oxygen, nutrients and insulin from the 
vascular compartment to the interstitial fluid surrounding the skeletal muscle fibers. The 
number of studies that have evaluated the impact of this endothelial barrier on the supply of 
oxygen and nutrients to the interstitium of skeletal muscle is surprisingly small. As far as the 
authors are aware it is not known today which % of the oxygen released from hemoglobin 
and the red blood cells is diffusing into the interstitium of skeletal muscle via the paracellular 
route (through the tight junctions between neighbouring ECs) and via the transcellular route 
(transendothelial transport (TET) from the luminal to the abluminal membrane through the 
cytosol of ECs). Still to answer the question whether O2 diffusion from capillary red bloods 
cells into the muscle interstitium limits VO2max in healthy humans and in sedentary obese and 
elderly individuals with and without type 2 diabetes and/or cardiovascular disease and 
ischemia, this is important information (Roca et  al. 1989; Spires et  al. 2012).  
The review of Mann et  al. (2003) comes to the conclusion that glucose transport across the 
luminal and abluminal membrane of the endothelium of the blood brain barrier occurs via a 
facilitative, energy-independent and saturable transport process by the GLUT-1 transporter. 
GLUT-1 has also been detected in the endothelium of the blood-retinal barrier, the cornea, 
and of freshly isolated and cultured bovine aorta ECs (bAECs). Total glucose transport rates 
across the retinal endothelium exceeded the metabolic rates of the retinal endothelium by far 
suggesting that GLUT-1 in ECs facilitates transendothelial transport (TET) of glucose into 
the underlying tissues. The driving force for glucose transport by GLUT-1 is the 
concentration gradient between the capillary lumen and the interstitium.  Davey et  al. (2007) 
using immunogold EM methods have shown that in rat heart GLUT-1 is the only glucose 
transporter present in the capillary ECs, while GLUT-4 was the dominant glucose transporter 
in cardiomyocytes. Bradley and Wagenmakers (unpublished data) using immuno-staining 
microscopy observed an intense GLUT-1 signal in ECs of capillaries in human vastus 
lateralis muscle and no GLUT-4, while the reverse was seen in the muscle fibres (Bradley et  
al. 2014), implying that the same GLUT distribution is present in human skeletal muscle as in 
rat heart. These data suggest that the main transport route of glucose is through the 
transcellular route with glucose transport facilitated by GLUT-1.  
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In addition Mann et   al. (2003) in their review come to the conclusion that ECs lining the 
blood-brain barrier and blood retinal barrier and cultured bAECs all express a large number 
of specific amino acid transport systems for practically all amino acids. There is no 
information on the presence of these amino acid transporters in the capillary endothelium of 
skeletal muscle, but the assumption is made that amino acids again are primarily transported 
into the skeletal muscle interstitium via the transcellular route.  
Fatty acids (FA), chylomicron triglycerides (CM-TG) and very low density lipoprotein 
triglycerides (VLDL-TG) are important fuels for human skeletal muscle both at rest 
(Bickerton et  al. 2007) and during exercise with peak oxidation rates occurring at intensities 
of 55-65% VO2max (Van Loon et  al. 2001). Plasma FA and TG are again delivered to muscle 
fibers via the capillaries. The enzyme lipoprotein lipase (LPL) is attached to the luminal 
membrane of capillary ECs and is responsible for the breakdown of CM-TG and VLDL-TG 
to FA. Until recently it was an open question how these FA are subsequently transported into 
the skeletal muscle interstitium for subsequent uptake in skeletal muscle, although the first 
study that observed a high concentration of FAT (fatty acid translocase)/CD36 in the 
endothelium of skeletal muscle, heart and adipose tissue of mice dates back to 1995 
(Greenwalt et  al. 1995). This observation was confirmed in 2004 with high quality confocal 
immuno-fluorescence microscopy images clearly showing that the FAT content of the 
capillary endothelium is much higher than in the skeletal muscle fibres (Vistisen et  al. 2004). 
FAT/CD36 today is regarded to be the most important FA transporter responsible for FA 
entry into skeletal muscle (Glatz et  al. 2010; McFarlan et  al. 2012). This conclusion is based 
on experiments with giant plasma membrane vesicles suggesting that postprandial increases 
in insulin and exercise/contraction lead to translocation of FAT from hypothetical 
microsomal storage depots (similar to GLUT-4 storage and translocation) to the plasma 
membrane of skeletal muscle fibers (reviewed by Glatz et  al. 2010). However, Vistisen et  al. 
(2004) using confocal immunofluorescence microscopy only detected FAT/CD 36 in the 
plasma membrane of the skeletal muscle membrane also in resting biopsies obtained in the 
fasted state in an intensity that was only a fraction of the stain in the capillary ECs. Hagberg 
et   al. (2010) also using immuno-staining methods observed that FA transporter proteins 
(FATP3 and FATP4) were expressed abundantly in the ECs of capillaries of mouse skeletal 
muscle, heart and adipose tissue. These proteins also facilitate the transport of FAs across the 
luminal and abluminal membrane. Iso et   al. (2013) observed that FA binding proteins 
(FABP4 and FABP5) are abundantly expressed in the ECL of mouse skeletal muscle 
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capillaries and venules (but not in arterioles, arteries and aorta). These proteins function as 
the transport vehicle for FAs diffusing through the cytosol from the luminal to the abluminal 
membrane of ECs. In skeletal muscle of FAT/CD36 KO mice (McFarlan et  al. 2012), with a 
low expression of FATP3 and FATP4 (Hagberg et  al. 2010), and with a double knock out for 
FABP4 and FABP5 (Iso et  al. 2013) skeletal muscle uptake of FA was substantially reduced, 
while the uptake of glucose and GLUT-4 expression in skeletal muscle was remarkably 
increased. Collectively these data provide convincing evidence that the main route for 
transport of FA across the ECL is via the transcellular route, that a low protein expression of 
FAT/CD36, FATPs and FABPs limits FA uptake in mouse skeletal muscle and that capillary 
ECs act as the gate-keepers for uptake of FAs into skeletal and as such may play a very 
important role in the distribution of lipids between skeletal muscle, subcutaneous adipose 
tissue and ectopic fat stores and, therefore, the mechanisms leading to insulin resistance of 
the skeletal muscle fibres (Fig. 3).  
Transport of insulin from the capillary lumen into the skeletal muscle interstitium has been 
investigated in great detail in a series of elegant studies by the research group of Professor 
Eugene Barrett primarily in cultured bovine aortic ECs (bAECs) (Wang et   al. 2008, 2009, 
2011, 2012, 2013) and in rat skeletal muscle in  vivo (Wang et  al. 2006). These studies are 
also placed in the context of the related human literature in reviews of Barrett et  al. (2009 and 
2011). Both in the in   vivo study investigating the rectus muscle of the rat and in in   vitro 
studies with bAECs ECs rapidly took up fluorescein isothiocyanate- (FITC-) labelled insulin. 
The fluorescent label allowed quantification of insulin uptake with confocal fluorescence 
microscopy.  In  the  in  vivo  study  in  rats  (Wang  et  al.  2006)  the  insulin  concentration  in  ECs  
by   far   exceeded   the   concentration   in   plasma   and   muscle   interstitium.   Both   the   insulin  
receptor   and   IGF-­1   receptor   mediated   insulin   transit   through   monolayers   of   bAECs   in   a  
process  involving  the  caveolae,  which  are  present  in  the  lipid  rafts  in  the  plasma  membrane  
(PM)  (Wang  et  al.  2006).  Adding insulin provoked the prompt translocation of both caveolin-
1 and eNOS to the PM and led to co-immunoprecipitation of these proteins, suggesting that 
insulin signaling brings these proteins together in lipid rafts in the PM (Wang et  al. 2009). 
Insulin   uptake   required   intact   insulin   signaling   via   both   the   phosphatidylinositol 3-kinase 
(PI3K) and  mitogen  activated  protein  kinase  (MAPK)  signaling  cascades  (Wang  et  al.  2008).  
Pre-­incubation  of  bAECs  with  the  pro-­inflammatory  cytokines  TNF-­D and  IL-­6  significantly  
diminished   insulin  uptake,   at   least   in  part  by   inhibiting  caveolin-­1   expression   (Wang  et  al.  
2011).  Wang et   al. (2012) found that exposure of bAECs to insulin within 5 min induced 
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substantial cortical actin filament remodeling. The remodeling was inhibited by inhibition of 
PI3K or MAPK signaling and disruption of actin microfilaments and lipid rafts with specific 
inhibitors. Knockdown of either caveolin-1 or Akt led to complete elimination of the insulin-
induced cortical actin filament remodeling. The conclusion of Wang et  al. (2012) was that 
insulin-induced cortical actin filament remodeling is required for TET of insulin and depends 
both on intact PI3K/Akt signaling and the presence of caveolin-1 in intact lipid rafts. Wang et  
al.   (2013) observed that L-NAME (NOS inhibitor) pretreatment of bAECs blocked FITC-
labelled insulin uptake, whereas pretreatment with L-arginine (converted into NO by eNOS) 
and the NO-donor sodium nitroprusside (SNP) enhanced insulin uptake. SNP also reversed 
the inhibition of insulin uptake in bAECs by L-NAME, wortmannin (PI3K inhibitor) and 
TNFD. SNP increased TET of 125I-labeled insulin with 40% in bAEC monolayers. SNP 
finally increased S-nitrosylation of the protein tyrosine phosphatase PTP1B which 
dephosphorylates tyrosine residues on the IR and IRS-1 and IRS-2. S-nitrosylation led to 
inactivation of PTP1B activity and an increase in insulin signaling leading to Ser473 
phosphoryalation of Akt. The conclusion of Wang et  al. (2013) was that a high endothelial 
NO concentration directly promotes insulin transport into ECs and TET of insulin via a 
mechanism that involves enhancement of S-nitrosylation, inhibition of the activity of PTP1B 
and enhanced insulin signaling. As enhanced insulin signaling activates eNOS (Fig. 2) and 
increases endothelial NO production, this implies that insulin stimulates its own uptake in 
ECs lining skeletal muscle capillaries (Barrett et  al. 2011).  
Permeability  surface  area  product  as  measure  of  transendothelial  glucose  transport  
Gudsbjörnsdóttir et  al. (2003) have combined forearm arteriovenous cannulations in healthy 
lean men with microdialysis of the brachioradialis muscle to measure arterial, venous and 
interstitial glucose concentrations. Using this approach the authors were able to make a direct 
calculation of the permeability surface area product (PS) of the ECL for glucose in this 
muscle. The PS depends both on the surface area of the ECL that is available for glucose 
uptake (and therefore on number of simultaneously perfused MVUs) and the permeability of 
the ECL for glucose. As GLUT1 is the only transporter detected in the capillary endothelium 
of human skeletal muscle (Bradley & Wagenmakers, unpublished), it is the GLUT1 protein 
content that determines permeability. A traditional oral glucose tolerance test increased the 
PS for glucose and the glucose uptake by the muscle about 2-fold in the 90-150 min period 
after glucose ingestion. During a steady state euglycemic hyperinsulinemic clamp PS for 
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glucose increased 10-fold and glucose uptake by the muscle increased 8-9 fold. These data 
provide convincing evidence that oral ingestion of glucose and insulin infusion lead to 
substantial increases in the recruitment of endothelial surface area in the muscle 
microvasculature and that these lead to proportional increases in muscle glucose uptake. As 
glucose transport across the ECL is mediated by the insulin insensitive GLUT-1 transporter it 
is unlikely that increases in endothelial permeability make a major contribution to the 
observed increases in PS, although increases by other currently unknown activation 
mechanisms cannot be excluded. 
Gudsbjörnsdóttir et  al. (2005) measured the PS for glucose and insulin during a steady state 
euglycemic hyperinsulinemic clamp in male individuals with type 2 diabetes (T2D) and age- 
and weight-matched obese controls with normal fasting glucose. The PS for glucose was 2.2-
fold lower in the patients with T2D diabetes than the obese controls and muscle glucose 
uptake was 1.7-fold lower in the patients. The absolute value for the PS for glucose in the 
lean men during the steady state phase of the euglycemic hyperinsulinemic clamp was 2.3 ± 
0.9 ml/min.100g in the study of Gudsbjörnsdóttir et  al. (2003) and the equivalent values in 
the obese controls and type 2 diabetes patients in Gudsbjörnsdóttir et  al. (2005) were 1.1 ± 
0.2 and 0.5 ± 0.1 ml/min.100g. The corresponding muscle glucose uptake rates were 4.4 ± 
1.2, 3.0 ± 0.4 and 1.8 ± 0.3 µmol/min.100g in the lean healthy men, obese controls and type 2 
diabetes patients, respectively. These data confirm that the patients with type 2 diabetes have 
by far the lowest insulin stimulated capacity for transcapillary passage of glucose into the 
muscle interstitium and that obese men have a lower capacity than lean men. The differences 
are likely to at least in part be the result of the reduction in the surface area resulting from 
reduced insulin stimulated increases in microvascular dilation and blood volume (Keske et  al. 
2009), but differences in endothelial GLUT-1 content between these groups can also make a 
contribution. 
Spires et   al. (2012) have used experimental measurements in combination with a 
computational model to calculate the endothelial PS during incremental moderate intensity 
exercise and among others observed a gradual increase in PS, which showed a linear 
relationship with the increase in blood flow through the skeletal muscle capillary bed. How 
can we translate this into recruitment of MVUs and capillaries in skeletal muscle? For 
reasons explained in the previous sections it is not known today which % of the MVUs in 
human (or animal) skeletal muscle is perfused in the resting state at a given time. The 
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occurrence of vasomotion with large differences in phase and frequency between different 
MVUs also implies that the MVUs are constantly switching between the closed and open 
position in resting muscles. However, given the fact that oxygen consumption by the 
combined skeletal muscles and blood flow through the muscle capillary bed increases 80 to 
100-fold going from rest to maximal exercise (Andersen & Saltin, 1985) it seems reasonable 
to assume that the % of MVUs in the open position is close to 100% during maximal exercise 
and much lower (maybe as low as 5-10%) in the resting state. However, over the course of 
minutes it is likely that all MVUs have been in the open position part of the time. This then 
implies that only a fraction of the ECL surface area will be available for transport of oxygen, 
glucose and FAs in the resting state, while most of this surface area will be recruited during 
maximal exercise. A gradual increase in the number of MVUs that are constantly open would 
provide a powerful mechanism to ensure that the supply of blood borne fuels and oxygen 
meets the growing energy-demand of the contracting muscle fibres. The authors of this 
review want to make the reader aware here that Poole et  al. (2013) have proposed that also at 
rest all capillaries in skeletal muscle are simultaneously perfused, but only over a fraction of 
their length with longitudinal recruitment occurring during exercise. It, however, is not clear 
to the authors of this review how such a recruitment pattern can be made compatible with the 
blood flow patterns to include vasomotion that has been observed in MVUs among others by 
Lund et  al. 1987 and Delashaw & Duling (1988).  
Shear  stress  signal  function  of  the  endothelial  glycocalyx  
The luminal surface of the endothelium is covered with a brush like glycocalyx layer 
(glycoproteins and proteoglycans), which is approximately 0.5 µm thick in capillaries and 4.5 
µm in arteries (Reitsma et al 2007; Weinbaum et al 2007). An important function of the 
glycocalyx is the translation of hemodynamic forces (shear forces exerted by flowing blood 
and individual blood cells passing through the narrow lumen of a TA) into vasodilatory 
responses during exercise. As such mechanical forces exerted on the glycocalyx are likely to 
be early signalling events leading to eNOS activation and exercise training induced increases 
in skeletal muscle microvascular density.   
The molecular mechanisms by which insulin increases muscle capillary blood flow 
There is today compelling evidence both in rat and humans that an insulin-mediated increase 
in microvascular perfusion of skeletal muscle is a conditional early event leading to increases 
of the transendothelial transport (TET) of both glucose and insulin into the interstitial fluid 
that surrounds the muscle fibres (reviewed by Barrett et al. 2009 & 2011 and Keske et  al. 
unpublished symposium review). Once the insulin concentration in the interstitium starts to 
increase (15-20 min after ingestion of a glucose load or start of an euglycemic 
hyperinsulinemic clamp, this leads to subsequent activation of the insulin signalling cascade, 
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GLUT-4 translocation to the plasma membrane and increased glucose uptake in skeletal 
muscle fibres (Vincent et  al. 2004).  
 
Important early information on the molecular mechanisms by which insulin is able to recruit 
additional blood flow in muscle capillaries has come from studies in cultured ECs (for 
references see Vincent et  al. 2003; Wagenmakers et  al. 2006; Muniyappa et  al. 2007; Keske 
et  al. unpublished symposium review).  These studies identified an insulin-signalling cascade 
(Insulin receptor/IRS-1/PI3-Kinase/PDK1/Akt/eNOS; Fig. 2), activation of which leads to 
increased production of nitric oxide (NO). NO produced in   vivo by the ECL is a potent 
vasodilator acting upon the smooth muscle cell layer in skeletal muscle arterioles. Insulin was 
found to activate the enzyme endothelial nitric oxide synthase (eNOS) among others by 
means of ser1176 phosphorylation in cultured rat ECs and ser1177 phosphorylation in cultured 
human ECs. Other signals found to activate eNOS in cultured ECs via ser1176/1177 
phosphorylation are fluid shear forces exerted on a cultured EC monolayer and exposure of 
cultured ECs to vascular endothelial growth factor-A (VEGF-A).  
With the current understanding of the role played by TAs in the blood supply to MVUs, the 
likely eNOS activation site by which physiological increases in insulin following meal 
ingestion lead to the simultaneous recruitment of a larger number of MVUs are the TAs. This 
has been confirmed by the observation of Cocks et  al. (2013b) that 80 min after the start of a 
hyperinsulinemic euglycemic clamp in lean Zucker rats eNOS ser1176 phosphorylation was 
increased by 14% (P< 0.05) in the ECL of TAs, while no increase was seen in the capillaries.  
Newman et  al. (2009), using Laser Doppler Flowmetry of skeletal muscle, observed that a 
hyperinsulinemic euglycemic clamp in rats induced an increase in the relative amplitude of 
the myogenic component of vasomotion which coincided with an increase in hindlimb 
glucose uptake. This observation suggested that the ability of insulin to recruit muscle 
microvascular blood flow is at least in part the result of increased arteriolar vasomotion in 
skeletal muscle. Vasomotion of TAs is also the likely mechanism to expose the ECL of a 
previously closed TA to the higher insulin concentration of the incoming blood. It is also 
possible that TET of insulin in open MVUs leads to increases in the interstitial insulin 
concentration and thus to the activation of the insulin receptor or IGF-1 receptor in the 
abluminal membrane of closed MVUs. There currently is no information on the density of 
these receptors on the luminal and abluminal endothelial membrane, implying that this back-
door mechanism cannot be excluded. It also cannot be excluded that adenosine or ATP or 
other vasodilators play a role in giving luminal plasma insulin access to the luminal 
membrane of the ECL of closed TAs in the period that the plasma and interstitial insulin 
concentrations are rising. The adenosine may be produced by ECs, vascular smooth muscle 
cells and also skeletal muscle fibres in which the metabolic rate is increased by rises in 
interstitial insulin that are not matched by the oxygen supply as most of the MVUs serving 
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that muscle fibre are in the closed position. Collectively these mechanisms will lead to an 
increase in the available capillary surface area and, therefore, result in increases in transport 
rates of insulin and glucose without the necessity of a measurable increase in total muscle 
blood. The latter has been observed in several studies (e.g. Raitakari et  al. 1996). Insulin as 
mentioned before also increases its own TET via a mechanism that involves eNOS activation, 
enhancement of S-nitrosylation of PTP1B inhibiting its phosphatase activity and therefore 
enhancing endothelial insulin signaling (Fig. 8 in Wang et  al. 2013). 
There also is evidence that there are impairments in the insulin-induced activation of eNOS in 
animal models of insulin resistance and patients with type 2 diabetes. Cocks et   al. 
(unpublished) did not find an increase in eNOS ser1176 phosphorylation during an euglycemic 
clamp in the ECL of TAs in obese Zucker rats, while a significant 14% increase was seen in 
lean Zucker rats. Tabit et   al. (2013) reported an insulin induced increase in eNOS1177 in 
freshly isolated venous ECs from nondiabetic controls, but not in diabetic patients (P=0.003), 
consistent with endothelial insulin resistance in type 2 diabetes. This study also provided 
convincing evidence that oxidative stress (nitrotyosine levels) and inflammation (nuclear 
factor NB activation) was higher in ECs from the patients and that protein kinase C-E activity 
was implicated in the endothelial insulin resistance. These data suggest that the mechanisms 
leading to insulin resistance in the ECL and in muscle fibres are quite similar (for comparison 
see Fig. 3; for further evidence and references see Wagenmakers et  al. 2006 and Muniyappa 
et  al. 2007). 
The molecular mechanisms by which an exercise-induced increase in blood shear stress 
increases muscle capillary blood flow 
Endurance exercise at moderate intensities always leads to parallel increases in capillary 
perfusion and total muscle perfusion. Endurance exercise for 1 h at 65% VO2max led to eNOS 
activation by means of increased eNOS ser1177 phosphorylation in a mixture of muscle 
capillaries and TAs (Cocks et   al. 2012; Cocks et   al. 2013a). The increase in shear stress 
sensed by the endothelial glycocalyx is likely to play a role in the activation mechanism. This 
again will allow recruitment of more MVUs and a higher blood flow rate in the recruited 
MVUs by maintaining a high blood flow rate for a longer fraction of the time via increased 
vasomotion activity. In addition, despite lack of published data to confirm this, such increases 
in eNOS phosphorylation are also likely to occur in lower order arterioles and the muscular 
feed arteries. This assumption is based on the observations of van Teeffelen & Segal (2000) 
that as metabolic demand of the contracting muscle fibres increases, vasodilatation ascends 
progressively from the TAs into larger arterioles and their feed arteries. The induction of this 
mechanism is NO independent (Budel et   al. 2003). Research of Segal & Jacobs (2001) 
generated evidence that electrical signals generated by ECs can travel rapidly along the ECL 
from TAs into their parent blood vessels, thereby leading to vasodilatation of the larger 
arterioles, resistance and feed arteries. This mechanism is called conductive vasodilatation 
(Segal & Jacobs, 2001) and contributes to the increases in skeletal muscle perfusion during 
exercise. The resultant increase in shear stress in these vessels is likely to lead to eNOS 
activation in lower order arterioles and muscular feed arteries. Acute endurance exercise has 
also been shown to activate eNOS via ser1177 phosphorylation in mouse aorta (Zhang et  al. 
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The molecular mechanisms by which an exercise-induced increase in the interstitial 
V E G F-A concentration increases muscle capillary blood flow 
Vascular endothelial growth factor-A (VEGF-A) is regarded to be the central angiogenic 
factor in skeletal muscle capillary growth in response to exercise training interventions (Hoier 
& Hellsten, 2014). Skeletal muscle fibres are an important source of VEGF-A in humans. 
Muscle fibres contain substantial VEGF-A stores in small vesicles present between the 
myofibrils, with smaller amounts of VEGF-A being present in cells located in the interstitial 
fluid that fills the space between capillaries and muscle fibres, to include ECs and pericytes. 
Hoier and Hellsten (2014) in their recent review propose that VEGF-A-containing vesicles 
translocate to the plasma membrane and secrete their content into the interstitial fluid during 
exercise. As VEGF-A mRNA expression is primarily increased after exercise, it is also 
proposed that the VEGF-A stores lost through secretion during exercise are rapidly 
replenished in the 12-24 h period after exercise. As VEGF-A is secreted during exercise it is 
impossible to separate the contribution made by increased blood shear stress and by VEGF-A 
to the increase in eNOS ser1177 phosphorylation seen by Cocks et  al. (2012 & 2013a) in the 
ECL of a mixed population of TAs and capillaries after 1 h of cycling exercise at 65% 
VO2max. As VEGF-A is approaching the ECL via the skeletal muscle interstitium it may also 
help to activate eNOS via receptors on the abluminal membrane of TAs to thus recruit 
previously closed MVUs. 
Activation of eNOS by increases in blood shear stress and interstitial VEGF during aerobic 
endurance exercise, therefore, are likely to both contribute to the mechanisms that lead to the 
recruitment of additional MVUs and maintenance of a higher mean blood flow in the 
recruited MVUs, but it is clear that there is an interaction between several locally produced 
vasodilators (NO, prostaglandins, ATP, adenosine) (for recent review see Mortensen & 
Saltin, 2014). There is evidence that NO and prostaglandins are the main vasodilators with a 
compensatory formation of the other vasodilator occurring when one is inhibited (Mortensen 
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VEGF-­B  controls  the  expression  of  endothelial  FA  transporter  proteins  
Four closely related vascular endothelium growth factor (VEGF) isoforms are expressed in 
human skeletal muscle (VEGF A-D). VEGF-A is best characterised because of its role in the 
angiogenic effect of exercise training. Until recently the role of VEGF-B in regulating blood 
vessel function was not known. Hagberg et  al.  (2010) made the observation that VEGF-B in 
mouse skeletal muscle co-expressed with a large cluster of nuclear genes encoding for 
mitochondrial proteins. This co-expression was unique for VEGF-B. Using a broad spectrum 
of molecular research methods, freshly isolated and cultured ECs and transgenic animal 
models, this study generated convincing evidence for the existence of a novel mechanism, 
which couples uptake and transendothelial transport of FA to the capacity of mitochondrial E-
oxidation (Fig. 4). In brief VEGF-B produced by skeletal muscle fibres is released to the 
interstitium and diffuses to the abluminal membrane of ECs in the capillary ECL. Here, it 
binds to VEGF receptor 1 and neuropilin 1 which are both expressed by the ECL. Signaling 
of VEGF-B via a PI3K dependent mechanism then leads to the abundant expression of 
FATP3 and FATP4 in the ECL and incorporation into the luminal and abluminal membrane 
and, therefore, leads to increased transendothelial transport of FAs into the muscle 
interstitium where they diffuse to the muscle plasma membrane. Hagberg et al. (2010) also 
performed a study in which 14C-oleate (a long-chain FA) was given to wildtype and VEGF-B 
(-/-) mice by oral gavage and the incorporation of the radioactive long-chain FA was 
measured in tissues. The incorporation into muscle, heart and brown adipose tissue of VEGF-
B (-/-) mice was much lower than in tissues of wild-type mice. In the VEGF-B (-/-) mice 
most of the radioactive FA accumulated in white adipose tissue pads. VEGF-B (-/-) mice also 
gained more weight with age and developed obesity as evidenced by 60-90% larger fat pads 
and a higher body fat mass.  
  
Conclusions 
The most important conclusion of this review is that the monolayer of ECs lining the lumen 
of skeletal muscle capillaries contains high concentrations of binding and transporters 
proteins, which help to facilitate the transport of glucose (GLUT1), FAs (FAT/CD36, 
FATP4, FATP5), insulin and amino acids across the luminal and abluminal plasma 
membrane and diffusion of FA (FABP3 and FABP4) through the cytosol of ECs. This 
implies that studies that aim to determine transport rates from the lumen of the capillary into 
the skeletal muscle fibre should consider the role of the ECL as a potential barrier (limiting 
skeletal muscle uptake) or as a facilitator (exceeding or driving the muscle uptake; eg the 
ability of the endothelial insulin transport system to create a higher insulin concentration in 
the cytosol of ECs than in the lumen of capillaries and in muscle interstitium). This finding 
also implies that studies using extracts of muscle homogenates and Western blots to measure 
the content of these transporters cannot assume that the measured concentration reflects the 
protein content of the muscle fibres, if the transporter is expressed in a much higher 
concentration in the capillary endothelium than in the plasma membrane or cytosol of skeletal 
muscle. Examples of the latter are FAT/CD36 content (Vistisen et  al. 2004) and FATP4 (Iso 
et  al. 2013). Use of Western blot data in that case may confound important isomer differences 
between the capillary endothelium and the skeletal muscle fibres. 
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Another important message is that a careful review of earlier publications (Lund et al. 1987; 
Delashaw & Duling 1988) using intravital microscopy of red blood cells moving in the 
microvasculature of the anterior tibialis muscle of hamsters confirms Microfil® cast images 
of rat skeletal muscle (Fig 1C) of Segal (2005) suggesting that MVUs are the smallest 
functional elements that can be used to adjust capillary blood flow in response to 
physiological stimuli (insulin, exercise, adrenaline) and metabolic demand of muscle fibres. 
The blood flow patterns observed in these studies suggest that some MVUs have no flow, 
some undergo cyclic vasomotion and some are continuously perfused with a coordinated 
response occurring in each of these cases in all capillaries sharing a common TA. This pattern 
is not in line with recent suggestions that all capillaries in skeletal muscle are simultaneously 
perfused also at rest, but only over a fraction of their length with longitudinal recruitment 
occurring during exercise (Poole et al., 2013). 
The recent observation (Hagberg et al. 2010) that the VEGF-B gene is co-expressed in mouse 
skeletal muscle and brown adipose tissue with nuclear genes encoding for mitochondrial 
proteins and simultaneously has a unique role in the expression of FATP3 and FATP4 in the 
capillary endothelium of these tissues is important for the following reasons: 1) The 
observation seems to provide a mechanism for the fact that meal derived lipids in lean 
healthy and physically active humans are preferentially channeled for storage and subsequent 
oxidation into skeletal muscle and subcutaneous adipose tissue (Bickerton et al 2007); 2) As 
VEGF-B production similar to VEGF-A is likely to be lower (and less frequent) in sedentary 
individuals, the latter similar to VEGF (-/-) mice are likely to deposit meal derived lipids in 
ectopic fat stores (visceral adipose tissue, around blood vessels and in man probably also in 
the liver) and develop obesity. As sedentary and obese individuals have a low capacity for fat 
oxidation in skeletal muscle this may also explain the accumulation of FA metabolites 
(DAGs and ceramides) in their muscle, which is known to lead to insulin resistance (Fig. 3) 
and eventually to chronic disease (type 2 diabetes and cardiovascular disease). Future 
research should investigate these hypotheses by making comparisons between trained and 
sedentary humans and studying the impact of obesity, ageing and type 2 diabetes on the 
protein content of endothelial nutrient and insulin transporters.  As VEGF-B controls the 
expression of FATP3 and FATP4 via VEGF receptor 1 and neuropilin 1 this research may 
also create opportunities for the development of novel pharmacological interventions to 
reverse the pathological metabolic consequences of obesity, ageing, type 2 diabetes and 
cardiovascular disease. 
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Figure  1.  Structure  and  anatomy  of  skeletal  muscle  microvasculature. 
Panel A shows a cross-sectional image of muscle fibres and their microvasculature. It 
historically and today still is common practice to use cross-sectional images of skeletal 
muscle to visualise and quantify the capillarisation of skeletal muscle fibres. This image 
shows in green the plasma membrane of the skeletal muscle fibres and the membrane 
surrounding the ECL of capillaries (visualised with an antibody stain against collagen IV, 
which is a main component of the basement membrane). The glycocalyx of the capillaries 
and of the larger 4th order arteriole (approximately 50 µm in diameter) was stained in red with 
a fluorescent lectin (Ulex europaeus). This unpublished image comes from the collection of 
Dr Chris Shaw and was obtained by Chris during his PhD with Anton Wagenmakers at the 
University of Birmingham, UK;  Panel B and C show microvascular casts in mouse gluteus 
maximus muscle. In these whole-mount preparations, the vasculature was cast using 
Microfil® and muscle fibres were cleared in glycerin to enhance the visibility of 
microvessels. Panel B shows that the arteriolar and venular networks are paired in skeletal 
muscle. A 3rd order arteriole (a) and its paired venule (v) both enter at left. Note the proximity 
of arteriolar-venular segments through the 4th order branches, which then branch into the TAs 
that supply red blood cells to the capillaries. The "shadows" of parallel muscle fibres and 
surrounding capillaries are oriented obliquely across the figure. Panel C shows that capillaries 
are organised into microvascular units (MVUs). TAs (arrowheads indicate 2 of the several 
that are present) branch off vertically from 4th order arterioles. Each TA gives rise to a group 
of approximately 20 capillaries. The capillaries in the MVU run half and half in both 
directions parallel to muscle fibres and have a length of approximately 1 mm.  The capillaries 
converge on collecting venules (arrows indicate 2 of the several which are present). Muscle 
fibres are transparent in this image. Panel B and C are reproduced with permission of the 
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author and the publisher from Segal SS (2005). Regulation of blood flow in the 
microcirculation. Microcirculation 12, 33-45. © John Wiley and Sons. Panel 1D is a visual 
representation of the relative size of the endothelial surface area in m2 present in arteries, the 
microvasculature and veins. Every blood vessel in the human vasculature is covered on the 
luminal side with a continuous monolayer of ECs. About 400 m2 ECL surface is present in 
skeletal muscle capillaries to generate the transport capacity for oxygen, fuels and hormones 
that is required to meet the high metabolic demands of skeletal muscle during aerobic 
exercise via recruitment of additional MVUs (compared to rest) and rhythmic increases in the 
dilatation of TAs and capillary blood flow in the recruited MVUs (compared to rest).   
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Figure  2.  Insulin  induced  vasodilatation  of  TAs  leads  to  increased  perfusion  of  muscle  
capillaries.    
Meal-induced increases in the plasma insulin concentration activate an insulin signalling 
cascade (Insulin receptor/IRS-1/PI3-Kinase/PDK1/Akt/eNOS), that is present in the ECL of 
the TAs. The endresult is an increase in nitric oxide (NO) production. NO is a potent 
vasodilator acting upon the smooth muscle cell layer in TAs. The simple version of the 
underlying mechanism is that insulin-induced increases in vasodilatation of TAs lead to 
recruitment of additional MVUs and capillaries that were not perfused before ingestion of the 
meal and, therefore, explain the observed increase in microvascular perfusion of skeletal 
muscle. The real mechanism probably is more complex as several studies have shown that the 
microvascular blood flow in skeletal muscle undergoes rhythmic oscillations attributable to 
spontaneous changes in the diameter of the TA lumen (Lund et al. 1987; Newman et   al. 
2009). This phenomenon is called 'arteriolar vasomotion'. Newman et  al. (2009) using laser 
Doppler flowmetry recently observed that a hyperinsulinemic euglycemic clamp in rats 
increased the arteriolar oscillations. The interpretation of this observation by the authors is 
that the insulin-induced increase in microvascular perfusion of skeletal muscle is at least in 
part due to an increase in the intensity of the vasomotion that occurs in TAs of skeletal 
muscle. The left panel of Fig. 2 is an adaptation of Fig. 1 published in Cohen et  al. (2000). 
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Figure  3.  Activation  of  the  insulin-­signalling  cascade  in  skeletal  muscle. 
In healthy trained individuals increases in the insulin concentration in the interstitial fluid 
surrounding muscle fibres leads to increased activation of the insulin signalling cascade and 
translocation of GLUT4 (main glucose transporter in muscle) to the plasma membrane. As 
muscle is the main tissue responsible for glucose uptake in the period after meal ingestion 
this will keep the rise in blood glucose concentration following ingestion of a meal relatively 
modest. As such healthy trained individuals have firm control on their blood glucose levels, 
both in the fasted period and after food intake. In sedentary, obese or elderly individuals and 
those with metabolic syndrome and type 2 diabetes high blood levels of fatty acids and 
triglycerides contribute to an excessive accumulation of lipid metabolites such as long chain 
fatty acyl-CoA, diacylglycerol and ceramide in skeletal muscle. This together with increased 
plasma levels of inflammatory cytokines in obese individuals (Berg & Scherer 2005) and 
local inflammation of the microvasculature in skeletal muscle  activates the serine kinases 
PKC, IKK and JNK (Wagenmakers et   al. 2006). These phosphorylate insulin receptor 
substrate-1 (IRS1) on serine residues leading to inactivation of IRS1 and downstream 
inactivation of the insulin signalling cascade. Ceramide accumulation also activates the 
phosphatase PP2A which dephosphorylates and inactivates Akt. These mechanisms 
collectively prevent activation of the insulin signalling cascade in skeletal muscle and, 
therefore, reduce insulin-mediated GLUT4 translocation and skeletal muscle glucose uptake. 
Reproduced with permission, from Shaw CS & Wagenmakers AJM, (2012), The  Biochemist, 
34, 20-23. © the Biochemical Society. 
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Figure  4.  Schematic  illustration  of  the  role  of  VEGF-­B  in  matching  transendothelial  FA  
transport  to  skeletal  muscle  FA  oxidation  capacity.  
Hagberg et   al.   (2010) made the observation that VEGF-B in mouse skeletal muscle co-
expressed in a large number of different physiological conditions with a large cluster of 
nuclear genes encoding for mitochondrial proteins. They subsequently generated strong 
supportive evidence for the existence of a novel mechanism, which couples uptake and 
transendothelial transport of FA to the capacity of mitochondrial E-oxidation in skeletal 
muscle. VEGF-B produced by skeletal muscle fibres was assumed to be released to the 
interstitium and then diffuse to the abluminal membrane of ECs in skeletal muscle capillaries, 
similar to the VEGF-A release by skeletal muscle during exercise (Hoier & Hellsten, 2014). 
Here, VEGF-B binds to its receptors (VEGF receptor 1 (VGRF1) and neuropilin 1 (NRP1)) 
which are both expressed by the ECs. Signalling of VEGF-B then leads to the abundant 
expression of FATP3 and FATP4 in the ECs and incorporation into the luminal and 
abluminal membrane and, therefore, is assumed to lead to increased TET of FAs into the 
muscle interstitium where FA are bound again to albumin to diffuse to the muscle plasma 
membrane and to be taken up and oxidised by skeletal muscle as described by Glatz et al. 
(2010). The red arrows in this Figure indicate the sequential steps in this novel mechanism as 
proposed by Hagberg et al. (2010). Other studies have shown that FAT/CD36 (Vistisen et  al. 
2004) and FABP4 and FABP5 (Iso et   al. 2013) are also expressed abundantly in ECs and 
contribute to the high capacity for TET of FAs, but Hagberg et  al. 2010 failed to generate 
evidence that expression of their genes was under the control of VEGF-B. It is also tempting 
to speculate that VEGF-B controls expression of the 1500 nuclear encoded genes in the ECs 
as the metabolic rate and protein turnover rate of ECs is high potentially because of repeated 
exposure to reactive oxygen species (ROS). It also cannot be excluded that some of the TET 
systems that help to increase endothelial permeability in the postprandial state and during 
exercise are energy (ATP) dependent (eg the insulin transport system which concentrates 
insulin in the ECs against a concentration gradient). This implies that ECs in trained inviduals 
should also have a high mitochondrial density to optimally support a high metabolic rate and 
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